Todd Foley, Director, 10% Owner at Entrada Therapeutics, Inc. (TRDA), bought 609,024 shares at $20.00 ($2.0M) on 2021-11-02, disclosed to the SEC on 2021-11-04.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 509,024 | $0 | 0.0% |
| 2 | $20.00 | 100,000 | $2.0M | 100.0% |
| Total | $3.28 avg | 609,024 | $2.0M | 100% |
| Filing → |
| ITOS | SELL | 2021-09-20 | $5.2M | — | Filing → |
| RPTX | SELL | 2021-07-13 | $1.8M | — | Filing → |
| RPTX | SELL | 2021-06-30 | $495K | — | Filing → |